ScreenerHero

IMCC IM Cannabis Corp.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · imcannabis.com
1.900USD-2.06%Mkt Cap: 3.13M $P/E: —

IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, an…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap3.13M USD
Enterprise Value13.18M USD
Revenue (TTM)45.80M USD
Gross Profit9.69M USD
Net Income (TTM)-11.32M USD
Revenue/Share210.27 USD
Last Price1.900 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees44
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.49
PEG—
EV/EBITDA-1.64
EV/Revenue0.29
P/S0.07
P/B-0.27
EPS (TTM)-71.04
EPS (Forward)-1.30
52W Range
1.6200% of range77.10
52W High77.10 USD
52W Low1.620 USD
Profitability
Gross Margin17.70%
Oper. Margin-27.54%
EBITDA Margin-17.55%
Profit Margin-20.68%
ROE1319.23%
ROA-35.67%
Growth
Revenue Growth-40.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF4.72M USD
CapEx (TTM)13.00K USD
FCF Margin-4.64%
FCF Yield-67.90%
Net Debt12.21M USD
Net Debt/EBITDA-1.52
Balance Sheet
Debt/Equity-18.96
Current Ratio0.56
Quick Ratio0.29
Book Value/Sh-7.15 USD
Cash/Share2.98 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 18, 2018
Splits
Last Split1:30
Split DateAug 27, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.65M
Float357.11K
Insiders34.40%
Institutions0.73%
Short Interest
Short Ratio0.3d
Short % Float7.71%
Short % Out.7.34%
Shares Short45.41K
Short (prev mo.)12.56K
Technical
SMA 502.987 (-36.4%)
SMA 20015.21 (-87.5%)
Beta2.21
S&P 52W Chg16.45%
Avg Vol (30d)5.63M
Avg Vol (10d)6.29M
Technical Indicators
RSI (14)41.0
MACD-0.3054
MACD Signal-0.2545
MACD Hist.-0.0509
BB Upper3.943 USD
BB Middle2.418 USD
BB Lower0.8925 USD
BB Width126.17%
ATR (14)0.6278 USD
Vol Ratio (20d)0.01x